Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities

Neurology. 2010 May 25;74(21):1724-31. doi: 10.1212/WNL.0b013e3181e04264.

Abstract

Background: Imaging determinations of the spatial extent of diffuse low-grade gliomas (DLGGs) are of paramount importance in evaluating the risk-to-benefit ratio of surgical resection. However, it is not clear how accurately preoperative conventional MRI can delineate DLGGs.

Methods: We report a retrospective histologic and imaging correlation study in 16 adult patients who underwent serial stereotactic biopsies for the diagnosis of untreated supratentorial well-defined and non-contrast-enhanced DLGG, in whom biopsy samples were taken within and beyond (OutBSs) MRI-defined abnormalities.

Results: Thirty-seven OutBSs that extended from 10 to 26 mm beyond MRI-defined abnormalities were studied. Immunostaining revealed MIB-1-positive cells (i.e., cycling cells) in all but 2 of the OutBSs. None of the MIB-1-positive cells coexpressed glial fibrillary acidic protein, and all of them coexpressed OLIG2. MIB-1-positive cells were cycling isolated tumor cells, because 1) their morphologic characteristics reflected those of tumor cells, 2) the number of MIB-1-positive cells per square centimeter was significantly higher than that of controls, 3) the number of MIB-1-positive cells per square centimeter was positively correlated with the tumor growth fraction (p = 0.012), and 4) the number of MIB-1-positive cells per square centimeter in OutBSs decreased with distance from the tumor (p = 0.003).

Conclusions: This study demonstrates, using a multiscale correlative approach, that conventional MRI underestimates the actual spatial extent of diffuse low-grade gliomas (DLGGs), even when they are well delineated. These results suggest that an extended resection of a margin beyond MRI-defined abnormalities, whenever feasible in noneloquent brain areas, might improve the outcome of DLGGs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Antinuclear / metabolism
  • Antibodies, Monoclonal / metabolism
  • Basic Helix-Loop-Helix Transcription Factors / metabolism
  • Biopsy / methods
  • Brain / metabolism
  • Brain / pathology*
  • Brain Neoplasms / diagnosis*
  • Female
  • Glial Fibrillary Acidic Protein / metabolism
  • Humans
  • Image Enhancement / methods
  • Magnetic Resonance Imaging*
  • Magnetic Resonance Spectroscopy / methods
  • Male
  • Middle Aged
  • Nerve Tissue Proteins / metabolism
  • Neurofilament Proteins / metabolism
  • Oligodendrocyte Transcription Factor 2
  • Oligodendroglioma / diagnosis*
  • Protons
  • Retrospective Studies
  • Statistics as Topic
  • Young Adult

Substances

  • Antibodies, Antinuclear
  • Antibodies, Monoclonal
  • Basic Helix-Loop-Helix Transcription Factors
  • Glial Fibrillary Acidic Protein
  • MIB-1 antibody
  • Nerve Tissue Proteins
  • Neurofilament Proteins
  • OLIG2 protein, human
  • Oligodendrocyte Transcription Factor 2
  • Protons